Skip to content

A Registration trial for Acute Exacerbation of COPD Patients and the Immunological Mechanism Research of Antioxygen Improving COPD Induced by Tabacoo Exposure

A Registration trial for Acute Exacerbation of COPD Patients and the Immunological Mechanism Research of Antioxygen Improving COPD Induced by Tabacoo Exposure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028214
Enrollment
Unknown
Registered
2019-12-15
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Case series:Nil

Sponsors

Secend Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female adults with any age; 2. Been diagnosed as or suspected of having moderate or severe acute exacerbation of COPD; 3. Be willing to attend the test and signed an informed consent; the compliance of the subjects has to be determined to meet the requirements of this study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe mentally illnesses who cannot complete the informed consent and/or the presentation of adverse reactions; 2. Unable to finish the initial questionnaire and pulmonary function; 3. Subjects participating in other drug clinical trials or intervention studies.

Design outcomes

Primary

MeasureTime frame
Demographic sociological characteristics;behavior factor;Disease phenotype;Medication regimen;Non-drug management;PEACE questionnaire;The CAT score;The mMRC score;The SGRQ score;The EXACT score;

Secondary

MeasureTime frame
Direct health costs;

Countries

China

Contacts

Public ContactZhao Hui

Secend Hospital of Shanxi Medical University

hui_zhao@sxmu.edu.cn+86 13835175536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026